P01
Preclinical
AAV-mediated gene therapy in a porcine model of Duchenne Muscular Dystrophy
Ina Luksch, Klinik und Poliklinik für Innere Medizin I, University Clinic Rechts der Isar, School of Medicine and Health, Technical University of Munich / DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany
P02
Preclinical
Leveraging Asymptomatic PAD as a Model for Translational Insights into Immune Regulation and Monocyte Contributions to Collateral Artery Formation
Henry Nording, Department of Internal Medicine V (Cardiology and Angiology), University of Kiel, and German Centre for Cardiovascular Research, Partner Site Hamburg/Kiel/Lübeck, Kiel, Germany / DZHK (German Centre for Cardiovascular Research), partner site Hamburg/Lübeck/Kiel, Lübeck, Germany / Cardioimmunology Group, Medical Clinic II, University Heart Center Lübeck, Lübeck, Germany
P03
Preclinical
Gene-enrichment analysis in dominant and recessive genotypes of HLHS patients
Elisa Mastantuono, First Department of Medicine, TUM Klinikum Rechts der Isar, Technical University of Munich, 81675 Munich, Germany
P04
Preclinical
Transcriptional Upregulation as a Potential Therapeutic Strategy for PKP2 Mutation-Related Cardiomyopathies
Solomon Kiprop Yator, TUM University Clinics, Clinic for Cardiology, Technical University of Munich
P05
Clinical
Eccentric hypertrophy impairs outcome after TAVR
Viktoria Obermeier, Department of Internal Medicine I (Cardiology), University Hospital rechts der Isar, Technical University of Munich, Munich, Germany
P06
Preclinical
Natural aging as a cardiovascular disease: insights from a non-human primate model
Mostafa Samak, Laboratory Animal Science Unit, German Primate Center, Leibniz Institute for Primate Research, Göttingen, Germany / German Center for Cardiovascular Research (DZHK), Partner Site Lower Saxony, Göttingen, Germany
P07
Preclinical
FYCO1 improves cardiac remodeling in response to ischemia by amplifying autophagic flux in vivo
Frauke Senger, Department of Internal Medicine III, University Hospital Heidelberg, Germany
P08
Preclinical
Assessing alginate biomaterials for aortic gene therapy vector delivery
Prithviraj Shetty, Department of Internal Medicine V, University of Kiel, and German Centre for Cardiovascular Research, Partner Site Hamburg/Kiel/Lübeck, Germany
P09
Preclinical
Vascular HDAC9 regulates pro-inflammatory responses to control neointima formation upon arterial damage
Federica Tosato, Institute for Stroke and Dementia Research, LMU Munich, Munich, Germany
P10
Preclinical
Single-Cell and Single-Nucleus Multiomics Reveal Cardiac Endothelial Cell Heterogeneity and
Novel Pathological Processes in Pressure Overload-Induced Hypertrophy
Giulia Demenego, Department of Cardiovascular Medicine, IRCCS Humanitas Research Hospital, via Manzoni 56, 20089 Rozzano (MI), Italy
P11
Preclinical
Immature neutrophils in myocardial infarction: dynamics, function, and therapeutic implications.
Zoe Möller-Ramon, Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians-Universität München, Germany / German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Germany
P12
Preclinical
Development of a Cre-Activated AAV9 Peptide Library for Targeted Selection in Cardiac Conduction Cells
Nicola Deyerling, Department of Internal Medicine V, University Hospital Schleswig-Holstein and University of Kiel, Kiel, Germany / German Centre for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Kiel, Germany
P13
Preclinical
Nanoparticle Based Enhancement and Retargeting of AAV-Mediated Gene Delivery
Seyed Amir Shakouri, Klinik und Poliklinik für Innere Medizin I, Klinikum rechts der Isar, Technical University Munich, Germany; German Center for Cardiovascular Research (DZHK), Munich Heart Alliance, Munich, Germany
P14
Preclinical
The HDAC9 risk locus in chronic inflammation in atherosclerosis
Nawraa Naser, Institute for Stroke and Dementia Research (ISD), LMU Munich, Munich, Germany
P15
Preclinical
Role of endothelial constitutive photomorphogenesis 9 (COP9) in atherosclerosis
Yue Yuan and Lea Klose, Institute for Stroke and Dementia Research (ISD), Klinikum der Universität München, Ludwig Maximilian University (LMU), Munich, Germany
P16
Preclinical
A Porcine Model for Cardiac Hypertrophy Induced by Catheter-Based Aortic Stent placement
Mara Corsten, Department of Internal Medicine I, Klinikum rechts der Isar, TU Munich, Germany / Center for Innovative Medical Models; LMU Munich, Germany
P17
Preclinical
A sympathetic nerve-driven neuroimmune crosstalk with macrophages synchronizes systemic sympathetic states to local immune programming
Christoph Gold, LMU Klinikum, Medizinische Klinik I, Munich
P18
Preclinical
Decoding Proangiogenic Immunity in Asymptomatic PAD: A Signature of Optimal Collateral Adaptation
Maximilian Leuner, Institute of Human Genetics, Universitätsklinikum Schleswig-Holstein, University of Lübeck and University of Kiel, 23562, Lübeck, Germany / Department of Internal Medicine V (Cardiology and Angiology), University of Kiel, and German Centre for Cardiovascular Research, Partner Site Hamburg/Kiel/Lübeck, Kiel, 24105, Germany / DZHK (German Centre for Cardiovascular Research), partner site Hamburg/Lübeck/Kiel, Lübeck, 23562, Germany
P19
Preclinical
Novel strategies to reactivate and trace regeneration capacity in adult cardiomyocytes
Lu Han, Max Planck Institute for heart and lung, Bad Nauheim, 61231, Germany / Cardiac Pulmonary Institute / DZHK
P20
Preclinical
Measurement of endothelial force transduction in vivo
Ario Dastmaltschi, Klinik und Poliklinik für Innere Medizin I, Klinikum rechts der Isar der Technischen Universität München, München
P21
Preclinical
Multidimensional profiling of systemic immunity unravels key roles of circulating CD4+ T cell axes in modulating infective endocarditis
Rainer Kaiser, Medizinische Klinik und Poliklinik I, University Hospital Ludwig-Maximilians University, Munich, Germany / DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Germany
P22
Preclinical
Carbon dots induce remodelling of ECM: potent application for vascular damage
Yingqiu Xie, Department of Biology, School of Sciences and Humanities, Nazarbayev University, Astana, 010000, Kazakhstan
P23
Preclinical
The dual role of TFPT in INO80-denpendent and independent pathways during heart development
Qing Yin, Group Boettger, Department of Cardiac Development and Remodeling, Max Planck Institute for Heart and Lung Research, Bad Nauheim, 61231, Germany
P24
Preclinical
LEA29Y expression affects myocardial scar formation after ischemia/reperfusion in pigs
Heinke Heymer, Department of Internal Medicine I, Klinikum rechts der Isar, TU Munich, Germany / Center for Innovative Medical Models; LMU Munich, Germany
P25
Preclinical
Characterization of a PLN R14del pig model using cell stress markers
Eva-Maria Männer, Department of Internal Medicine I, Klinikum rechts der Isar, TU Munich, Germany
P26
Clinical
Protected-PCI-Registry at TUM University Hospital Rechts der Isar – First results of our monocentric study on impella-protected-PCI
Sebastian Bufler, TUM Universitätsklinikum Rechts der Isar
P27
Preclinical
Engineering miniature CRISPR-Cas proteins for gene editing in human cardiomyocytes
Jessica Kornherr, Department of Cardiology, TUM University Hospital - Klinikum rechts der Isar, Technical University of Munich / DZHK
Copyright ©2025 Lumina Partners Europe Limited